Bionor (Norway)

Bionor (Norway)

Bionor Holding AS is a Norwegian biotechnology company, developing vaccines targeted at rapidly mutating virus infections such as HIV, Hepatitis C and Influenza. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Bionor (Norway), Norway, covering academic research published from 2002 to 2025. Read More.


Open Access Percentage

56%


Total
Publications

71


Total Open
Publications

40


Total
Citations

1.4K


Open Access
Percentage

56%


Total
Publications

71


Total Open
Publications

40


Total
Citations

1.4K

Wikipedia

Website

download

Breakdown

18% 32% 7% 43%

Publisher Open

18%

Both

32%

Other Platform Open

7%

Closed

43%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

012345678910Total Publications
200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Open

Closed

Publisher Open

31%OA Journal

OA Journal 31%

11

Hybrid 55%

20

No Guarantees 14%

5

Other Platform Open

Institution 79%

22

Domain 25%

7

Preprint 14%

4

Public 14%

4

Other Internet 4%

1

Other Platform Locations

Name

Platform Type

Publications

LA Referencia
Institution
16
doaj.org OAI-PMH Repository
Institution
8
PubMed Central
Domain
7
University of Oslo
Institution
3
unil.ch OAI-PMH Repository
Institution
3
Swiss School of Archaeology in Greece
Institution
3
Figshare
Public
3
University of Groningen
Institution
2
Research Square
Preprint
2
fiocruz.br OAI-PMH Repository
Institution
2
1 / 3

Data updated 12 August 2026

Share

Share

Share